Shimul Shah, MD
Transplant Surgery · Boston, MANPI 1811962327
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (37.9%), speaking fees and education — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Genentech USA, Inc. at 39.3% of the total. Reporting peaked in 2023 at $3,885 and has fallen 99.5% since, to $20 in 2025.
Across 22 payments — averaging $379.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$3K
- Intuitive Surgical$2K
- Sirtex Medical Inc$2K
- Organ Recovery Systems, Inc.$920
- Medtronic$154
- Johnson & Johnson$39
- plus $56 from 3 others
Across 20 payments — averaging $94,772 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Organ Recovery Systems, Inc.$1.9M
What the payments were for
- Consulting fees$3,16538%
- Speaking & faculty fees$1,75021%
- Travel & lodging$6067%
- Food & beverage$1,32616%
- Education$1,50018%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 2 | $3,281 |
| Intuitive Surgical | 9 | $2,146 |
| Sirtex Medical Inc | 1 | $1,750 |
| Organ Recovery Systems, Inc. | 4 | $920 |
| Medtronic | 1 | $154 |
| Johnson & Johnson | 2 | $39 |
| TELA Bio, Inc. | 1 | $24 |
| Organox Ltd | 1 | $20 |
| Angiodynamics, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TECENTRIQ$3,281
- SIR-Spheres Microspheres$1,750
- DAVINCI XI$1,500
- Da Vinci Surgical System$520
- Signia$154
How this compares
$8,347 in reported general payments places this provider in the 85th percentile of 23 transplant surgery providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Valganciclovir Hcl | 14 | $2,555 |
| Prednisone | 14 | $80 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $65 |
Paid to pharmacies, not to this prescriber.
Other transplant surgery in Boston
- Stefan TulliusBoston$25K
- Tatsuo KawaiBoston$10K
- Martin Dib MarambioBoston$6K
- Yanik BababekovBoston$5K
- Shoko KimuraBoston$2K
- Amitabh GautamBoston$2K
- Despoina DaskalakiBoston$2K
- Vanessa CowanBoston$2K
- Angela ChenBoston$1K
- Sayeed MalekBoston$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.